HLA-DRB3 antibody
Quick Overview for HLA-DRB3 antibody (ABIN6937422)
Target
See all HLA-DRB3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- This MAb reacts with the HLA-DRB3 antigen, a member of MHC class II molecules.It does not cross react with HLA-DP and HLA-DQ. HLA-DR is a heterodimeric cell surface glycoprotein comprised of a 36 kDa alpha (heavy) chain and a 28 kDa beta (light) chain. It is expressed on B-cells, activated T-cells, monocytes/macrophages, dendritic cells and other non-professional APCs. In conjunction with the CD3/TCR complex and CD4 Molecules, HLA-DR is critical for efficient peptide presentation to CD4+ T cells. HLA-DR antigens also occur on a variety of epithelial cells and their corresponding neoplastic counterparts.
-
Cross-Reactivity (Details)
- Human. Baboon. Chimpanzee. Monkey. Squirrel. Dog.
-
Purification
- 1.0mg/ml of Ab purified from Bioreactor by Protein A/G.
-
Immunogen
- Human REH cells (non-T, non-B leukemia cell line)
-
Isotype
- IgG2a kappa
-
-
-
-
Application Notes
-
Known_Application: Flow Cytometry (1-2 μg/million cells), Immunofluorescence (1-2 μg/mL), Optimal dilution for a specific application should be determined.
Positive_Control: Ramos, Daudi or HuT78 cells. Tonsil or lymph node.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Prepared in 10 mM PBS, WITHOUT BSA and Azide.
-
Preservative
- Azide free
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.
-
Expiry Date
- 24 months
-
-
- HLA-DRB3 (Major Histocompatibility Complex, Class II, DR beta 3 (HLA-DRB3))
-
Alternative Name
- HLA-DRB3
-
Background
-
HLA class II histocompatibility antigen DR beta 3 chain, HLADR3B, Major histocompatibility complex, class II DR beta 3,HLA-DRB (MHC II)
Cellular localisation: Cell Surface -
Molecular Weight
- ~28kDa (beta chain)
-
Gene ID
- 3123, 534322
-
UniProt
- P01911
-
Pathways
- TCR Signaling, Positive Regulation of Peptide Hormone Secretion, Production of Molecular Mediator of Immune Response, Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-